Segment Reporting (Details)	3 Months Ended								12 Months Ended
	Dec. 31, 2025 USD ($)	Sep. 30, 2025 USD ($)	Jun. 30, 2025 USD ($)	Mar. 31, 2025 USD ($)	Dec. 31, 2024 USD ($)	Sep. 30, 2024 USD ($)	Jun. 30, 2024 USD ($)	Mar. 31, 2024 USD ($)	Dec. 31, 2025 USD ($) Segment	Dec. 31, 2024 USD ($)
Segment Reporting [Abstract]
Number of operating segments | Segment									1
Number of reportable segments | Segment									1
Segment Expenses [Abstract]
Total operating expenses									$ 31,543,959	$ 36,321,195
Interest income									1,217,241	2,514,816
Interest expense									(5,338,607)	(4,673,174)
Benefit for income taxes									1,169,820	869,169
Net loss	$ (7,562,919)	$ (9,009,411)	$ (9,434,208)	$ (8,488,967)	$ (7,952,352)	$ (10,726,658)	$ (8,327,897)	$ (10,603,477)	(34,495,505)	(37,610,384)
Operating Segment [Member] | PDS [Member]
Segment Expenses [Abstract]
Salaries and benefits									12,128,616	15,282,537
Professional fees									4,955,128	4,819,562
General administrative expenses									1,452,946	1,438,833
Clinical development expenses									4,158,848	6,480,674
Other development expenses									8,848,421	8,299,589
Total operating expenses									31,543,959	36,321,195
Net loss									(34,495,505)	(37,610,384)
Reconciling Item [Member]
Segment Expenses [Abstract]
Interest income									1,217,241	2,514,816
Interest expense									(5,338,607)	(4,673,174)
Benefit for income taxes									$ 1,169,820	$ 869,169